Abstract Library

#544 Second Primary Tumor in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): Data From a Retrospective Observational Unicentric Study

Introduction: It is known that GEPNETs are associated with a high incidence of second primary tumors, especially in the context of inherited syndromes and synchronous injuries to the intestine.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Fonseca P, Álvarez C, Pérez Q, Frunza M, Gutierrez E,

Keywords: gastroenteropancreatic neuroendocrine tumors, second primary tumor, synchronous tumor,

#257 Doxorubicin, Etoposide and Cisplatin as first-line Treatment in Advanced Adrenocortical Carcinoma

Introduction: Adrenocortical carcinoma (ACC) is a rare cancer with poor prognosis in advanced setting due to its low chemosensibility. Mitotane and cisplatin-based regimens are the most frequently used treatments.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca F, Vieitez J, Crespo G, Frunza M, Izquierdo M,

Keywords: adrenocortical carcinoma, chemotherapy, cisplatin-regimen, Doxorrubicin, Etoposide, Mitotane,

#253 Description and Treatment of GEP NETs in a Spanish Hospital During 10 Years

Introduction: In our area the GEP NET incidence is similar to that of gastric and exocrine pancreatic cancers consequently being important to know their characteristics and the most convenient therapeutic approach.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: J Fonseca P, Vieitez J, Galvan J, Crespo G, Frunza M,

Keywords: gastroenteropancreatic neuroendocrine tumors, histology, chemotherapy, streptozocin-based regimen,